Latest News

Featured News

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody^{^®} iSCIB1+

Jul 22, 2025

Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded

June 15, 2022

First patient dosed in Modi-1 Phase 1 clinical trial

June 13, 2022

Modi-1 Phase 1/2 clinical trial open for recruitment

April 13, 2022

Broadening of COVIDITY Phase 1 clinical trial in South Africa

March 29, 2022

Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™

March 17, 2022

Update on COVIDITY Phase 1 clinical trial in South Africa

January 31, 2022

4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
5

No results found.

Regulatory News Archive

JOIN OUR MAILING LIST

Sign up for news updates to stay up to date with Scancell.